SpectRx, Inc. Schedules Date for Release of Third Quarter 2004 Results

Name	Symbol	Market	Type
Spear Alpha ETF	NASDAQ:SPRX	NASDAQ	Exchange Traded Fund

Name

Symbol

Market

Type

Spear Alpha ETF

NASDAQ:SPRX

NASDAQ

Exchange Traded Fund

	Price Change	% Change	Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Traded	Last Trade
	-0.06	-0.26%	22.99	21.50	23.60	23.10	22.87	23.02	29,931	22:59:00

Price Change

% Change

Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Traded

Last Trade

-0.06

-0.26%

22.99

21.50

23.60

23.10

22.87

23.02

29,931

22:59:00

SpectRx, Inc. Schedules Date for Release of Third Quarter 2004 Results

11/11/2004 12:45pm

PR Newswire (US)

Spear Alpha ETF (NASDAQ:SPRX)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Spear Alpha ETF Charts.

SpectRx, Inc. Schedules Date for Release of Third Quarter 2004 Results NORCROSS, Ga., Nov. 4 /PRNewswire-FirstCall/ -- SpectRx, Inc. (OTC:SPRX) (BULLETIN BOARD: SPRX) announced today that it plans to release third quarter 2004 results after the market closes on Wednesday, November 10, 2004. SpectRx will host a conference call and webcast to review the Company's financial results on Thursday, November 11, 2004 at 11:30 a.m. Eastern Time. The webcast will be made available at http://www.fulldisclosure.com/ or http://www.ccbn.com/ . The telephone number to participate in the conference call is 800-889-0817. A replay of the conference call will be made available until November 17, 2004, by dialing 800-642-1687, passcode 2051502. About SpectRx SpectRx, Inc. (OTC:SPRX) (BULLETIN BOARD: SPRX) is a diabetes management company developing and providing innovative solutions for insulin delivery and glucose monitoring. SpectRx markets the SimpleChoice(R) line of innovative diabetes management products, which include insulin pump disposable supplies. SpectRx also plans to develop a consumer device for continuous glucose monitoring. The company is commercializing its non-invasive cancer detection technology through subsidiary company Guided Therapeutics, Inc, which SpectRx intends to separately finance with private funds. For more information, visit SpectRx's web sites at spectrx.com, mysimplechoice.com and guidedtherapeutics.com . DATASOURCE: SpectRx, Inc. CONTACT: Media, Bill Wells, or Financial, Thomas H. Muller, Jr., of SpectRx, Inc., +1-770-242-8723 Web site: http://www.spectrx.com/ http://www.mysimplechoice.com/ http://www.guidedtherapeutics.com/ http://www.fulldisclosure.com/ http://www.ccbn.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

SPRX Spear Alpha ETF